← Open Payments lookup

YU-MEI CHEN: Open Payments

NPI 1649746736 · MANCHESTER, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$658 in 34 payments from 10 companies in 2025. Trend: 2023 $615 · 2024 $581 · 2025 $658

Food & beverage: $658
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.16$300
Neurocrine BioSciences, Inc.5$98
E.R. Squibb & Sons, L.L.C.3$83
Otsuka America Pharmaceutical, Inc.3$48
Janssen Pharmaceuticals, Inc2$34
Becton, Dickinson and Company1$24
Alkermes, Inc.1$23
Takeda Pharmaceuticals U.S.A., Inc.1$16
ABBVIE INC.1$16
Lundbeck LLC1$15

Products named: FANAPT, INGREZZA, COBENFY, REXULTI, INVEGA SUSTENNA, ARISTADA, TRINTELLIX, VRAYLAR.

Industry payments across NH — which companies pay providers there.